ETV4 and hepatocellular carcinoma: For instance, in hepatocellular carcinoma (HCC), HSPA8 functions as a co‐activator of the transcription factor ETV4, leading to the upregulation of PHLDA2, thereby facilitating the progression of liver cancer [37].